acrylonitrile has been researched along with Metastase in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, J; Corrie, P; di Pietro, M; Fitzgerald, RC; Januszewicz, W; Liu, H | 1 |
| Abuodeh, YA; Ahmed, KA; Arrington, JA; Caudell, JJ; Echevarria, MI; Etame, AB; Forsyth, PA; Harrison, LB; Hogue, C; Johnstone, PA; Khushalani, NI; Kim, S; Kim, Y; Naghavi, AO; Patel, BG; Sahebjam, S; Sarangkasiri, S; Stallworth, DG; Yu, M | 1 |
2 other study(ies) available for acrylonitrile and Metastase
| Article | Year |
|---|---|
A sinister black finding in the stomach.
Topics: Acrylonitrile; Aged; Aniline Compounds; Barrett Esophagus; Benzimidazoles; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Melanoma; Mutation; Neoplasm Metastasis; Paclitaxel; Prognosis; Stomach; Tomography, X-Ray Computed; Tubulin Modulators; Uveal Neoplasms | 2019 |
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.
Topics: Acrylonitrile; Adolescent; Adult; Aged; Aged, 80 and over; Aniline Compounds; Brain Neoplasms; Combined Modality Therapy; CTLA-4 Antigen; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Programmed Cell Death 1 Receptor; Proto-Oncogene Proteins B-raf; Radiosurgery | 2016 |